Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation Meeting Abstract
| Authors: | Poppiti, K.; Lin, A.; Adel, N. G.; Hilden, P.; Castro-Malaspina, H. |
| Abstract Title: | Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394452506186 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.4623.4623 |
| Notes: | Meeting Abstract: 4623 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
333Castro-Malaspina -
44Adel -
108Hilden -
48Lin -
2Poppiti
Related MSK Work